Dyslipidemia and thyroid dysfunction in patients with type II Diabetes Mellitus treated at the Social Security Institute period 2022

Abstract

Type 2 diabetes mellitus is a chronic disease that affects the way the body processes glucose (blood sugar). In this type of diabetes, the body does not produce enough insulin or does not effectively use the insulin it produces. The objective of the research was to determine dyslipidemia and thyroid dysfunction in patients with type II Diabetes Mellitus (DM2) treated at the Instituto de Seguridad Social Jipijapa during the period 2022. We used a retrospective cross-sectional analytical observational methodology with a quantitative approach, the study population will be composed of all patients who have been treated at the Institute of Social Security Jipijapa during the year 2022, the sampling was convenience or non-probabilistic sampling where data is presented only from people with a diagnosis of Diabetes Mellitus type II (DM2), It was shown that there is a significance of 0.077, indicating that there is no relationship between thyroid dysfunction and dyslipidemia in diabetic patients, it is concluded that the presence of diabetes mellitus may increase the risk of suffering from dyslipidemia and therefore the cardiovascular risk in patients.